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Case Report
Pleomorphic Hyalinizing Angiectatic Tumor
of Soft Parts
Hui-Chin Peng,1 Ming-Te Huang,2 Da-Jeng Chen,3 Ting-Kai Leung,4 Jan-Show Chu5*
Pleomorphic hyalinizing angiectatic tumor (PHAT) of soft parts is a rare, nonmetastasizing tumor of un-
certain lineage which was first reported in 1996. Here, we report a case of PHAT and review the literature.
A 49-year-old man presented with a soft and progressively enlarging mass over the right buttock for several
years. On suspicion that the mass was a right gluteal lipoma, he underwent surgical excision. The excised
lesion measured 14 × 6 × 3.5 cm. It had a variegated appearance with a white–tan to yellowish color on the
cut surface. Some punctate hemorrhage and vessel thrombosis were seen. Microscopically, the tumor was
a PHAT characterized by clusters of ectatic, fibrin-lined, thin-walled vessels, which were surrounded by a
mitotically inert, spindled, pleomorphic, neoplastic stroma that contained a variable inflammatory com-
ponent. Immunohistochemical study showed that the tumor cells were positive for CD34, and negative
for S-100, HMB45 and actin. The patient experienced local recurrence 6 months later. The recurrent tumor
was widely excised. No evidence of metastasis was found during the 18 months after the second operation.
The recurrent lesion had a microscopic appearance that was similar to the initial lesion.
Key Words: pleomorphic hyalinizing angiectatic tumor, soft tissue tumor
Pleomorphic hyalinizing angiectatic tumor (PH
AT) of soft parts was first reported by Smith et al
in 1996.1 It is characterized by clusters of ectatic,
fibrin-lined, thin-walled vessels which are sur-
rounded by a spindled or pleomorphic neoplas-
tic stroma that contains a variable inflammatory
component. The tumor cells are similar to those
of malignant fibrous histiocytoma but differ from
them by having a low mitotic figure, intranuclear
cytoplasmic inclusion and CD34 expression. The
peculiar vascular pattern, low mitotic figure, intran-
uclear cytoplasmic inclusion and mast cell infil-
tration are also reminiscent of neurilemmoma.
However, PHAT usually shows an infiltrative bor-
der and no S-100 protein expression.1–4 Here, we
report a case of PHAT and review the literature.
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Case Report
A 49-year-old man had a soft, progressively en-
larged, non-painful mass over the right buttock
for several years. He came to our hospital be-
cause the mass increased in size. There was no
personal or family history of major medical prob-
lems. Hemography and serum chemistry data were
within the normal range. Physical examination
showed a mass that measured about 10 × 7 cm; it
was deep-seated and immovable in the right but-
tock. No skin change or other associated symp-
tom was found. Under the suspicion of right
gluteal lipoma, he underwent surgical excision
in December 2005. During the operation, a well-
circumscribed, fusiform, yellowish tumor was
noted deep in the muscle layer. The excised le-
sion measured 14 × 6 × 3.5 cm in size (Figure 1A).
It had a variegated appearance with a white–
tan to yellowish color on the cut surface. Some
punctate hemorrhage and vessel thrombosis were
observed.
Microscopically, there were obvious clusters of
thin-walled ectatic blood vessels of various sizes
scattered in the adipose tissue. Luminal thrombus
formation, subendothelial fibrin deposition, and
perivascular hyalinization were clearly seen in these
vessels (Figure 1B). In addition to the impressive
vascular structure, plump pleomorphic cells or
slender, wavy spindle cells were randomly arranged
in sheets between the angiectatic vessels (Figure
1C). Mitotic figures were scarce. The extent of vas-
cular clustering and tumor cell pleomorphism
was more prominent at the center of the lesion.
The slender, wavy spindle cells were mainly dis-
tributed around the periphery of the lesion (Figure
1D). Intranuclear inclusions were seen within
the pleomorphic cells (Figure 1C). Hemosiderin
deposition, myxoid area and moderate inflam-
matory cell infiltration were also noted. The above
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Figure 1. (A) Gross appearance of specimen of pleomorphic hyalinizing angiectatic tumor of soft parts excised at first 
operation. (B) Characteristic clusters of ectatic, fibrin-lined, thin-walled vessels [hematoxylin and eosin staining (HE);
original magnification, 100×]. (C) Pleomorphic neoplastic cells in between the angiectatic vessels (arrow; HE; original
magnification, 200×) and tumor cell with intranuclear inclusion (inset; HE; original magnification, 400×). (D) Area of low
cellularity, with bland, slender neoplastic cells (HE; original magnification, 100×).
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characteristics were typical for PHAT. An infiltra-
tive border was observed under the microscope.
Meanwhile, immunohistochemical study showed
that the tumor cells were positive for CD34, and
negative for S-100 (Figures 2A and 2B), HMB45
and actin.
The patient experienced local recurrence 6
months later. Computed tomography showed an
ill-defined mass that measured 2 cm in diameter
in the right gluteus muscle. There was relative
pre-contrast high density, about 100 HU, but no
post-contrast enhancement. Positron emission
tomography showed mildly increased uptake ac-
tivity of the tumor (the standardized uptake value
of the lesion was 1.4). The recurrent tumor was
widely excised. No evidence of metastasis from
the recurrent lesion was found in the 18 months
following the second operation. The recurrent le-
sion showed some plump pleomorphic cells and
hyalinized vessels within the adipose tissue, which
was microscopically similar to the initial lesion.
Discussion
PHAT was first reported by Smith et al in 1996.1
They described 14 cases of a low-grade tumor with
features of both neurilemmoma and malignant
fibrous histiocytoma (MFH), yet distinctive from
both entities in several aspects. PHAT is a tumor
of adults, which is mainly located in the subcuta-
neous tissue of the lower extremities. We reviewed
studies published in the years following the paper
by Smith et al, and found 74 cases of PHAT in
patients aged 10–89 years (median = 56 years),
without sex predilection (41 female and 33 male).
Tumor diameter ranged from 0.3 to 26.0 cm. Three
tumors were located in the intramuscular area, and
the others were in the suprafascial subcutaneous
area. The legs (n=24) and feet/ankles (n=20) were
the most frequently involved site. Other locations
such as the upper extremities, buttocks, inguinal
region, knee/patella, chest wall, shoulder, axilla,
back, hands, waist, breasts and perineum were also
reported.2,4–9
The microscopic characteristics of PHAT are
clusters of different-sized, ectatic vessels that show
subendothelial and intraluminal fibrin deposits
due to vascular injury and leakage. The organiza-
tion of the fibrin creates prominent perivascular
collagen cuffs, which, in some tumors, give rise 
to large areas of stromal hyalinization. In be-
tween these scattered vessels, there are plump,
spindle, and round pleomorphic cells that are
arranged randomly in sheets, which simulates
neurilemmoma, or in long fascicles that simulate
fibrosarcoma. Mitotic figures are very scarce. The
pleomorphic cells contain easily identifiable in-
tranuclear inclusions. The cells adjacent to the
vessels contain fine dusty hemosiderin pigment
within their cytoplasm. Mast cells can be seen in the
tumor stroma. Flope et al identified a distinctive,
low-grade, partially myxoid lesion that appeared to
represent a precursor lesion of PHAT.2 So-called
“early PHAT” is defined by hypocellular prolifer-
ation of generally bland, hemosiderin-stippled
spindle cells that infiltrate fat and surrounded con-
geries of small damaged vessels. The background
is variably myxoid. Ultrastructural analysis of the
tumor cell shows no recognized feature that im-
plies specific mesenchymal differentiation.1,3,10,11
A primitive fibroblast or fibrohistiocytic origin is
favored to date. Immunohistochemically, CD34
and S-100 protein are useful markers.1,2 PHAT
expresses CD34 and vimentin but does not stain
for S-100 protein. This is different from neurilem-
moma. PHAT also has expressed CD99 in some
studies.3,10,12 Epithelial membrane antigen, actin,
BA
Figure 2. Cells from pleomorphic hyalinizing angiectatic
tumor of soft parts were (A) positive for CD34 and (B)
negative for S-100 protein (original magnification, 200×).
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desmin, CD31 and von Willebrand factor are not
expressed by PHAT. The pronounced pleomor-
phism of the tumor, together with our inability to
identify features of a specific mesenchymal line-
age (despite the application of both immunohis-
tochemical and ultrastructural techniques), could
make MFH a convenient broad group into which
this tumor can be placed. However the peculiar
low level of mitosis, odd pleomorphic cells with
intranuclear inclusions, and ectatic damaged ves-
sels are rarely seen in MFH. Moreover, flow cy-
tometry has shown diploidy and there have been
no reports of metastasis.7,10,12 All of these features
make PHAT worthy of being separated from MFH.
Local excision is the best therapeutic approach,
but PHAT has to be closely followed up. PHAT
has a local recurrence rate of about 33%.2 Some
patients have experienced multiple recurrences
or high-grade malignant changes.1,2,6
The clinical impression of PHAT is usually a
slow-growing benign tumor. However, its micro-
scopic features must be differentiated from those
of several other tumor.7 By combining the clini-
cal picture and microscopic details, we can make
the appropriate diagnosis. Our patient presented
with an infiltrative border and positivity for CD34,
which meant that a diagnosis of neurilemmoma
could be excluded. Scarce mitosis, pleomorphic
and/or spindle stromal cells and characteristic
vascular structure fitted with a diagnosis of PHAT
rather than MFH. Computed tomography and
positron emission tomography both indicated a
tumor with low malignant activity.
The most notable feature of PHAT is the
hyalinizing angiectatic vascular structure. How-
ever, its significance and pathogenesis are not yet
fully understood. Smith et al proposed that the
vessels arise from encroachment of normal vessels
by tumor cells.1 The slow growth of the tumor re-
sults in clustering, angiectasia, and subtle endothe-
lial injury rather than massive vascular destruction
and tumor necrosis that are characteristic of high-
grade malignancy. Another cause of the vascular
leakage could be the presence of mast cells, which
might release vasoactive substances during tissue
injury induced by tumor infiltration.1 In contrast,
Flope et al suggested that the vascular change is
an early pivotal event by itself, after observing
damaged vessels in the early lesion in which the
number of tumor cells was low.2
Groisman et al suggested that angiogenesis and
the angiogenic factor vascular endothelial growth
factor (VEGF) play a role in the development of
PHAT.12 They found VEGF expression in tumor
cells and endothelial cells of the non-hyalinized
vessels but not the hyalinized ones. Thus they con-
cluded that the progressive perivascular hyalin-
ization induces hypoxia and therefore stimulates
angiogenesis via increased VEGF production. Our
case showed more engorged, damaged vessels and
more pleomorphic tumor cells centrally of the
tumor. Lesser vascular changes and wavy spindle
tumor cells were located peripherally of the tumor.
This phenomenon, so-called “classic PHAT” cen-
trally and “early PHAT” peripherally, is similar to
Flope’s observation.2 The recurrent lesion in the
present case showed some pleomorphic tumor
and inflammatory cell infiltration around some
ectatic vessels. Although there were no marked
clusters or vessel engorgement, the fibrinoid de-
generative change in the vessel walls was obvious.
From the timing of these events and our observa-
tions of the tumor specimen, we agree with Flope’s
opinion that vascular leakage and damage were the
key features of this tumor, rather than the result
of tumor cell engulfment.2 The peculiar pleomor-
phism of tumor cells is a late, time-dependent,
degenerative phenomenon.
In summary, we describe a typical case of PHAT
in terms of both early stages and of recurrence.
However, the histogenesis of PHAT is still un-
clear, even with the recent immunohistochemical
and ultrastructural analyses, therefore, the patho-
genesis can only be inferred from microscopic ob-
servation. More cases will need to be reported to
understand the pathogenesis of PHAT.
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